ReviewCurrent hematologic malignancy reports2018
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma.
Bei Hu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it
ReviewCurrent hematologic malignancy reports2018
Bei Hu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.